Hikma Pharmaceuticals PLC

Hikma Pharma Extends Recall Of Acetaminophen Injection

23 7 2024 03:11:57 提供 NASDAQ US Markets

Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets

17 6 2024 02:45:01 提供 NASDAQ US Markets

Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US

29 4 2024 09:07:49 提供 NASDAQ US Markets

Hikma Pharma FY Profit Increases

22 2 2024 03:52:27 提供 NASDAQ US Markets

Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US

05 2 2024 07:48:52 提供 NASDAQ US Markets

Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa

08 1 2024 03:35:52 提供 NASDAQ US Markets

Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15

01 9 2023 01:51:58 提供 NASDAQ Stocks

Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

03 8 2023 03:46:32 提供 NASDAQ US Markets

Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation

04 5 2023 20:30:46 提供 NASDAQ Stocks

Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

12 4 2023 02:25:53 提供 NASDAQ US Markets

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

23 2 2023 04:10:05 提供 NASDAQ US Markets

Hikma accuses Amarin of suppressing generic versions of heart pill

22 2 2023 17:13:30 提供 NASDAQ US Markets

Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.

03 1 2023 03:15:34 提供 NASDAQ US Markets

Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma

29 4 2022 23:58:14 提供 NASDAQ US Markets

U.S. FTC approves Hikma deal for Custopharm with conditions

19 4 2022 14:04:52 提供 NASDAQ US Markets

Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down

24 2 2022 03:43:25 提供 NASDAQ US Markets

Hikma To Acquire Teligent's Canadian Assets - Quick Facts

17 1 2022 03:32:15 提供 NASDAQ US Markets

Hikma Pharma Launches Outsourced Sterile Compounding Business - Quick Facts

10 1 2022 02:48:45 提供 NASDAQ US Markets